{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["curcumin", "liposomes", "nanocarriers", "nanocurcumin", "neurological disorders"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32033365", "DateRevised": {"Year": "2023", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "02", "Day": "05"}], "Language": ["eng"], "ELocationID": ["430", "10.3390/jcm9020430"], "Journal": {"ISSN": "2077-0383", "JournalIssue": {"Volume": "9", "Issue": "2", "PubDate": {"Year": "2020", "Month": "Feb", "Day": "05"}}, "Title": "Journal of clinical medicine", "ISOAbbreviation": "J Clin Med"}, "ArticleTitle": "Curcumin's Nanomedicine Formulations for Therapeutic Application in Neurological Diseases.", "Abstract": {"AbstractText": ["The brain is the body's control center, so when a disease affects it, the outcomes are devastating. Alzheimer's and Parkinson's disease, and multiple sclerosis are brain diseases that cause a large number of human deaths worldwide. Curcumin has demonstrated beneficial effects on brain health through several mechanisms such as antioxidant, amyloid \u03b2-binding, anti-inflammatory, tau inhibition, metal chelation, neurogenesis activity, and synaptogenesis promotion. The therapeutic limitation of curcumin is its bioavailability, and to address this problem, new nanoformulations are being developed. The present review aims to summarize the general bioactivity of curcumin in neurological disorders, how functional molecules are extracted, and the different types of nanoformulations available."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, School of Medicine, Bam University of Medical Sciences, Bam 44340847, Iran."}], "LastName": "Salehi", "ForeName": "Bahare", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania."}], "LastName": "Calina", "ForeName": "Daniela", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania."}], "LastName": "Docea", "ForeName": "Anca Oana", "Initials": "AO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Natural Products Research, Dr. Koirala Research Institute for Biotechnology and Biodiversity, Kathmandu 44600, Nepal."}], "LastName": "Koirala", "ForeName": "Niranjan", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Natural Products Research, Dr. Koirala Research Institute for Biotechnology and Biodiversity, Kathmandu 44600, Nepal."}], "LastName": "Aryal", "ForeName": "Sushant", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Italian National Research Council, Rome (CNR), 98158 Messina, Italy."}], "LastName": "Lombardo", "ForeName": "Domenico", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental and Chemical Engineering, University of Calabria, 87036 Rende (CS), Italy."}], "LastName": "Pasqua", "ForeName": "Luigi", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran 1991953381, Iran."}], "LastName": "Taheri", "ForeName": "Yasaman", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Facultad de Medicina, Universidad del Azuay, 14-008 Cuenca, Ecuador."}], "LastName": "Marina Salgado Castillo", "ForeName": "Carla", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition and Dietetics, Faculty of Pharmacy, University of Concepcion, Concepcion 4070386, Chile."}, {"Identifier": [], "Affiliation": "Unidad de Desarrollo Tecnol\u00f3gico, Universidad de Concepci\u00f3n UDT, Concepcion 4070386, Chile."}], "LastName": "Martorell", "ForeName": "Miquel", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, University of Porto, Alameda Prof. Hern\u00e2niMonteiro, 4200-319 Porto, Portugal."}, {"Identifier": [], "Affiliation": "Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal."}], "LastName": "Martins", "ForeName": "Nat\u00e1lia", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Agricultural and Environmental Sciences, Milan State University, 20133 Milan, Italy."}], "LastName": "Iriti", "ForeName": "Marcello", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Agriculture and Food Systems, The University of Melbourne, Melbourne 3010, Australia."}], "LastName": "Suleria", "ForeName": "Hafiz Ansar Rasul", "Initials": "HAR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zabol Medicinal Plants Research Center, Zabol University of Medical Sciences, Zabol 61615-585, Iran."}], "LastName": "Sharifi-Rad", "ForeName": "Javad", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "J Clin Med", "NlmUniqueID": "101606588", "ISSNLinking": "2077-0383"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Hatcher H., Planalp R., Cho J., Torti F.M., Torti S.V. Curcumin: From ancient medicine to current clinical trials. Cell. Mol. Life Sci. 2008;65:1631\u20131652. doi: 10.1007/s00018-008-7452-4.", "ArticleIdList": ["10.1007/s00018-008-7452-4", "PMC4686230", "18324353"]}, {"Citation": "Farooqui T., Farooqui A.A. Chapter 2\u2014Curcumin: Historical Background, Chemistry, Pharmacological Action, and Potential Therapeutic Value. In: Farooqui T., Farooqui A.A., editors. Curcumin for Neurological and Psychiatric Disorders. Academic Press; New York, NY, USA: 2019. pp. 23\u201344.", "ArticleIdList": ["10.1016/B978-0-12-815461-8.00002-5"]}, {"Citation": "Anand P., Thomas S.G., Kunnumakkara A.B., Sundaram C., Harikumar K.B., Sung B., Tharakan S.T., Misra K., Priyadarsini I.K., Rajasekharan K.N., et al. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem. Pharmacol. 2008;76:1590\u20131611. doi: 10.1016/j.bcp.2008.08.008.", "ArticleIdList": ["10.1016/j.bcp.2008.08.008", "18775680"]}, {"Citation": "Vogel A., Pelletier J. Examen chimique de la racine de Curcuma. J. Pharm. 1815;1:289\u2013300."}, {"Citation": "Gupta S.C., Patchva S., Koh W., Aggarwal B.B. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin. Exp. Pharmacol. Physiol. 2012;39:283\u2013299. doi: 10.1111/j.1440-1681.2011.05648.x.", "ArticleIdList": ["10.1111/j.1440-1681.2011.05648.x", "PMC3288651", "22118895"]}, {"Citation": "Menon V.P., Sudheer A.R. Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol. 2007;595:105\u2013125. doi: 10.1007/978-0-387-46401-5_3.", "ArticleIdList": ["10.1007/978-0-387-46401-5_3", "17569207"]}, {"Citation": "Yeung A.W.K., Horbanczuk M., Tzvetkov N.T., Mocan A., Carradori S., Maggi F., Marchewka J., Sut S., Dall\u2019Acqua S., Gan R.Y., et al. Curcumin: Total-Scale Analysis of the Scientific Literature. Molecules. 2019;24:1393. doi: 10.3390/molecules24071393.", "ArticleIdList": ["10.3390/molecules24071393", "PMC6480685", "30970601"]}, {"Citation": "Khajehdehi P., Zanjaninejad B., Aflaki E., Nazarinia M., Azad F., Malekmakan L., Dehghanzadeh G.R. Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: A randomized and placebo-controlled study. J. Ren. Nutr. 2012;22:50\u201357. doi: 10.1053/j.jrn.2011.03.002.", "ArticleIdList": ["10.1053/j.jrn.2011.03.002", "21742514"]}, {"Citation": "Akazawa N., Choi Y., Miyaki A., Tanabe Y., Sugawara J., Ajisaka R., Maeda S. Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women. Nutr. Res. 2012;32:795\u2013799. doi: 10.1016/j.nutres.2012.09.002.", "ArticleIdList": ["10.1016/j.nutres.2012.09.002", "23146777"]}, {"Citation": "Wojcik M., Krawczyk M., Wojcik P., Cypryk K., Wozniak L.A. Molecular Mechanisms Underlying Curcumin-Mediated Therapeutic Effects in Type 2 Diabetes and Cancer. Oxid. Med. Cell. Longev. 2018;2018 doi: 10.1155/2018/9698258.", "ArticleIdList": ["10.1155/2018/9698258", "PMC5884026", "29743988"]}, {"Citation": "Chandran B., Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother. Res. 2012;26:1719\u20131725. doi: 10.1002/ptr.4639.", "ArticleIdList": ["10.1002/ptr.4639", "22407780"]}, {"Citation": "Kumar S., Ahuja V., Sankar M.J., Kumar A., Moss A.C. Curcumin for maintenance of remission in ulcerative colitis. Cochrane Database Syst. Rev. 2012;10 doi: 10.1002/14651858.CD008424.pub2.", "ArticleIdList": ["10.1002/14651858.CD008424.pub2", "PMC4001731", "23076948"]}, {"Citation": "Cole G.M., Teter B., Frautschy S.A. Neuroprotective effects of curcumin. Adv. Exp. Med. Biol. 2007;595:197\u2013212. doi: 10.1007/978-0-387-46401-5_8.", "ArticleIdList": ["10.1007/978-0-387-46401-5_8", "PMC2527619", "17569212"]}, {"Citation": "Trebatick\u00e1 J., \u010eura\u010dkov\u00e1 Z. Psychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy? Oxid. Med. Cell. Longev. 2015;2015:248529. doi: 10.1155/2015/248529.", "ArticleIdList": ["10.1155/2015/248529", "PMC4477218", "26180581"]}, {"Citation": "Bhat A., Mahalakshmi A.M., Ray B., Tuladhar S., Hediyal T.A., Manthiannem E., Padamati J., Chandra R., Chidambaram S.B., Sakharkar M.K. Benefits of curcumin in brain disorders. BioFactors. 2019;45:666\u2013689. doi: 10.1002/biof.1533.", "ArticleIdList": ["10.1002/biof.1533", "31185140"]}, {"Citation": "Ng T.P., Chiam P.C., Lee T., Chua H.C., Lim L., Kua E.H. Curry consumption and cognitive function in the elderly. Am. J. Epidemiol. 2006;164:898\u2013906. doi: 10.1093/aje/kwj267.", "ArticleIdList": ["10.1093/aje/kwj267", "16870699"]}, {"Citation": "Tai Y.H., Lin Y.Y., Wang K.C., Chang C.L., Chen R.Y., Wu C.C., Cheng I.H. Curcuminoid submicron particle ameliorates cognitive deficits and decreases amyloid pathology in Alzheimer\u2019s disease mouse model. Oncotarget. 2018;9:10681\u201310697. doi: 10.18632/oncotarget.24369.", "ArticleIdList": ["10.18632/oncotarget.24369", "PMC5828200", "29535835"]}, {"Citation": "McClure R., Ong H., Janve V., Barton S., Zhu M., Li B., Dawes M., Jerome W.G., Anderson A., Massion P., et al. Aerosol Delivery of Curcumin Reduced Amyloid-beta Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer\u2019s Disease. J. Alzheimers Dis. 2017;55:797\u2013811. doi: 10.3233/JAD-160289.", "ArticleIdList": ["10.3233/JAD-160289", "PMC5848215", "27802223"]}, {"Citation": "Ng Q.X., Koh S.S.H., Chan H.W., Ho C.Y.X. Clinical Use of Curcumin in Depression: A Meta-Analysis. J. Am. Med. Dir. Assoc. 2017;18:503\u2013508. doi: 10.1016/j.jamda.2016.12.071.", "ArticleIdList": ["10.1016/j.jamda.2016.12.071", "28236605"]}, {"Citation": "WHO . Neurological Disorders: Public Health Challenges. World Health Organization (WHO) Press; Geneva, Switzerland: 2006."}, {"Citation": "Gomez-Pinilla F., Nguyen T.T. Natural mood foods: The actions of polyphenols against psychiatric and cognitive disorders. Nutr. Neurosci. 2012;15:127\u2013133. doi: 10.1179/1476830511Y.0000000035.", "ArticleIdList": ["10.1179/1476830511Y.0000000035", "PMC3355196", "22334236"]}, {"Citation": "Williams C.M., El Mohsen M.A., Vauzour D., Rendeiro C., Butler L.T., Ellis J.A., Whiteman M., Spencer J.P. Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic. Biol. Med. 2008;45:295\u2013305. doi: 10.1016/j.freeradbiomed.2008.04.008.", "ArticleIdList": ["10.1016/j.freeradbiomed.2008.04.008", "18457678"]}, {"Citation": "Salehi B., Shivaprasad Shetty M., V Anil Kumar N., \u017divkovi\u0107 J., Calina D., Oana Docea A., Emamzadeh-Yazdi S., Sibel K\u0131l\u0131\u00e7 C., Goloshvili T., Nicola S. Veronica Plants\u2014Drifting from Farm to Traditional Healing, Food Application, and Phytopharmacology. Molecules. 2019;24:2454. doi: 10.3390/molecules24132454.", "ArticleIdList": ["10.3390/molecules24132454", "PMC6651156", "31277407"]}, {"Citation": "Salehi B., Sharifi-Rad J., Capanoglu E., Adrar N., Catalkaya G., Shaheen S., Jaffer M., Giri L., Suyal R., Jugran A.K. Cucurbita Plants: From Farm to Industry. Appl. Sci. 2019;9:3387. doi: 10.3390/app9163387.", "ArticleIdList": ["10.3390/app9163387"]}, {"Citation": "Salehi B., Capanoglu E., Adrar N., Catalkaya G., Shaheen S., Jaffer M., Giri L., Suyal R., Jugran A.K., Calina D. Cucurbits Plants: A Key Emphasis to Its Pharmacological Potential. Molecules. 2019;24:1854. doi: 10.3390/molecules24101854.", "ArticleIdList": ["10.3390/molecules24101854", "PMC6572650", "31091784"]}, {"Citation": "Carroll R.E., Benya R.V., Turgeon D.K., Vareed S., Neuman M., Rodriguez L., Kakarala M., Carpenter P.M., McLaren C., Meyskens F.L., Jr., et al. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev. Res. (Phila.) 2011;4:354\u2013364. doi: 10.1158/1940-6207.CAPR-10-0098.", "ArticleIdList": ["10.1158/1940-6207.CAPR-10-0098", "PMC4136551", "21372035"]}, {"Citation": "Ullah F., Liang A., Rangel A., Gyengesi E., Niedermayer G. High bioavailability curcumin: An anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation. Arch. Toxicol. 2017;91:1623\u20131634. doi: 10.1007/s00204-017-1939-4.", "ArticleIdList": ["10.1007/s00204-017-1939-4", "28204864"]}, {"Citation": "Jakubek M., Kej\u00edk Z., Kapl\u00e1nek R., Hrom\u00e1dka R., \u0160andrikov\u00e1 V., S\u00fdkora D., Antonyov\u00e1 V., Urban M., Dytrych P., Mikula I. Strategy for improved therapeutic efficiency of curcumin in the treatment of gastric cancer. Biomed. Pharmacother. 2019;118:109278. doi: 10.1016/j.biopha.2019.109278.", "ArticleIdList": ["10.1016/j.biopha.2019.109278", "31387004"]}, {"Citation": "Ghalandarlaki N., Alizadeh A.M. Nanotechnology-applied curcumin for different diseases therapy. BioMed Res. Int. 2014;2014 doi: 10.1155/2014/394264.", "ArticleIdList": ["10.1155/2014/394264", "PMC4066676", "24995293"]}, {"Citation": "Maiti P., Dunbar G.L. Use of Curcumin, a Natural Polyphenol for Targeting Molecular Pathways in Treating Age-Related Neurodegenerative Diseases. Int. J. Mol. Sci. 2018;19:1637. doi: 10.3390/ijms19061637.", "ArticleIdList": ["10.3390/ijms19061637", "PMC6032333", "29857538"]}, {"Citation": "Aqil F., Munagala R., Jeyabalan J., Vadhanam M.V. Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett. 2013;334:133\u2013141. doi: 10.1016/j.canlet.2013.02.032.", "ArticleIdList": ["10.1016/j.canlet.2013.02.032", "PMC3815990", "23435377"]}, {"Citation": "Schiborr C., Kocher A., Behnam D., Jandasek J., Toelstede S., Frank J. The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol. Nutr. Food Res. 2014;58:516\u2013527. doi: 10.1002/mnfr.201300724.", "ArticleIdList": ["10.1002/mnfr.201300724", "24402825"]}, {"Citation": "Zhu L.N., Mei X., Zhang Z.G., Xie Y.P., Lang F. Curcumin intervention for cognitive function in different types of people: A systematic review and meta-analysis. Phytother. Res. 2019;33:524\u2013533. doi: 10.1002/ptr.6257.", "ArticleIdList": ["10.1002/ptr.6257", "30575152"]}, {"Citation": "Iqbal M., Sharma S.D., Okazaki Y., Fujisawa M., Okada S. Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: Possible role in protection against chemical carcinogenesis and toxicity. Pharmacol. Toxicol. 2003;92:33\u201338. doi: 10.1034/j.1600-0773.2003.920106.x.", "ArticleIdList": ["10.1034/j.1600-0773.2003.920106.x", "12710595"]}, {"Citation": "Nie D., Bian Z., Yu A., Chen Z., Liu Z., Huang C. Ground and excited state intramolecular proton transfer controlled intramolecular charge separation and recombination: A new type of charge and proton transfer reaction. Chem. Phys. 2008;348:181\u2013186. doi: 10.1016/j.chemphys.2008.02.065.", "ArticleIdList": ["10.1016/j.chemphys.2008.02.065"]}, {"Citation": "Jovanovic S.V., Steenken S., Boone C.W., Simic M.G. H-Atom Transfer Is A Preferred Antioxidant Mechanism of Curcumin. J. Am. Chem. Soc. 1999;121:9677\u20139681. doi: 10.1021/ja991446m.", "ArticleIdList": ["10.1021/ja991446m"]}, {"Citation": "Paramera E.I., Konteles S.J., Karathanos V.T. Microencapsulation of curcumin in cells of Saccharomyces cerevisiae. Food Chem. 2011;125:892\u2013902. doi: 10.1016/j.foodchem.2010.09.063.", "ArticleIdList": ["10.1016/j.foodchem.2010.09.063"]}, {"Citation": "Serafini M.M., Catanzaro M., Rosini M., Racchi M., Lanni C. Curcumin in Alzheimer\u2019s disease: Can we think to new strategies and perspectives for this molecule? Pharmacol. Res. 2017;124:146\u2013155. doi: 10.1016/j.phrs.2017.08.004.", "ArticleIdList": ["10.1016/j.phrs.2017.08.004", "28811228"]}, {"Citation": "Pari L., Tewas D., Eckel J. Role of curcumin in health and disease. Arch. Physiol. Biochem. 2008;114:127\u2013149. doi: 10.1080/13813450802033958.", "ArticleIdList": ["10.1080/13813450802033958", "18484280"]}, {"Citation": "Reddy P.H., Manczak M., Yin X., Grady M.C., Mitchell A., Tonk S., Kuruva C.S., Bhatti J.S., Kandimalla R., Vijayan M. Protective effects of Indian spice curcumin against amyloid-\u03b2 in Alzheimer\u2019s disease. J. Alzheimers Dis. 2018;61:843\u2013866. doi: 10.3233/JAD-170512.", "ArticleIdList": ["10.3233/JAD-170512", "PMC5796761", "29332042"]}, {"Citation": "Ringman J.M., Frautschy S.A., Cole G.M., Masterman D.L., Cummings J.L. A potential role of the curry spice curcumin in Alzheimer\u2019s disease. Curr. Alzheimer Res. 2005;2:131\u2013136. doi: 10.2174/1567205053585882.", "ArticleIdList": ["10.2174/1567205053585882", "PMC1702408", "15974909"]}, {"Citation": "Zbarsky V., Datla K.P., Parkar S., Rai D.K., Aruoma O.I., Dexter D.T. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson\u2019s disease. Free Radic. Res. 2005;39:1119\u20131125. doi: 10.1080/10715760500233113.", "ArticleIdList": ["10.1080/10715760500233113", "16298737"]}, {"Citation": "Jagatha B., Mythri R.B., Vali S., Bharath M.S. Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: Therapeutic implications for Parkinson\u2019s disease explained via in silico studies. Free Radic. Biol. Med. 2008;44:907\u2013917. doi: 10.1016/j.freeradbiomed.2007.11.011.", "ArticleIdList": ["10.1016/j.freeradbiomed.2007.11.011", "18166164"]}, {"Citation": "Xie L., Li X.-K., Takahara S. Curcumin has bright prospects for the treatment of multiple sclerosis. Int. Immunopharmacol. 2011;11:323\u2013330. doi: 10.1016/j.intimp.2010.08.013.", "ArticleIdList": ["10.1016/j.intimp.2010.08.013", "20828641"]}, {"Citation": "Qureshi M., Al-Suhaimi E.A., Wahid F., Shehzad O., Shehzad A. Therapeutic potential of curcumin for multiple sclerosis. Neurol. Sci. 2018;39:207\u2013214. doi: 10.1007/s10072-017-3149-5.", "ArticleIdList": ["10.1007/s10072-017-3149-5", "29079885"]}, {"Citation": "Abdolahi M., Tafakhori A., Togha M., Okhovat A.A., Siassi F., Eshraghian M.R., Sedighiyan M., Djalali M., Honarvar N.M., Djalali M. The synergistic effects of \u03c9-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-\u03b1 gene expression and serum level in migraine patients. Immunogenetics. 2017;69:371\u2013378. doi: 10.1007/s00251-017-0992-8.", "ArticleIdList": ["10.1007/s00251-017-0992-8", "28478481"]}, {"Citation": "Bulboac\u0103 A.E., Bolboac\u0103 S.D., St\u0103nescu I.C., Sfr\u00e2ngeu C.A., Porfire A., Tefas L., Bulboac\u0103 A.C. The effect of intravenous administration of liposomal curcumin in addition to sumatriptan treatment in an experimental migraine model in rats. Int. J. Nanomed. 2018;13:3093. doi: 10.2147/IJN.S162087.", "ArticleIdList": ["10.2147/IJN.S162087", "PMC5975613", "29872296"]}, {"Citation": "He Q., Jiang L., Man S., Wu L., Hu Y., Chen W. Curcumin reduces neuronal loss and inhibits the NLRP3 inflammasome activation in an epileptic rat model. Curr. Neurovasc. Res. 2018;15:186\u2013192. doi: 10.2174/1567202615666180731100224.", "ArticleIdList": ["10.2174/1567202615666180731100224", "PMC6327116", "30062967"]}, {"Citation": "Drion C., van Scheppingen J., Arena A., Geijtenbeek K., Kooijman L., van Vliet E., Aronica E., Gorter J. Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo\u2014In search of potential anti-epileptogenic strategies for temporal lobe epilepsy. J. Neuroinflamm. 2018;15:212. doi: 10.1186/s12974-018-1247-9.", "ArticleIdList": ["10.1186/s12974-018-1247-9", "PMC6056921", "30037344"]}, {"Citation": "Kalani A., Kamat P.K., Kalani K., Tyagi N. Epigenetic impact of curcumin on stroke prevention. Metab. Brain Dis. 2015;30:427\u2013435. doi: 10.1007/s11011-014-9537-0.", "ArticleIdList": ["10.1007/s11011-014-9537-0", "PMC4216637", "24788895"]}, {"Citation": "Lan C., Chen X., Zhang Y., Wang W., Wang W.E., Liu Y., Cai Y., Ren H., Zheng S., Zhou L. Curcumin prevents strokes in stroke-prone spontaneously hypertensive rats by improving vascular endothelial function. BMC Cardiovasc. Disord. 2018;18:43. doi: 10.1186/s12872-018-0768-6.", "ArticleIdList": ["10.1186/s12872-018-0768-6", "PMC5831583", "29490624"]}, {"Citation": "Dong W., Yang B., Wang L., Li B., Guo X., Zhang M., Jiang Z., Fu J., Pi J., Guan D. Curcumin plays neuroprotective roles against traumatic brain injury partly via Nrf2 signaling. Toxicol. Appl. Pharmacol. 2018;346:28\u201336. doi: 10.1016/j.taap.2018.03.020.", "ArticleIdList": ["10.1016/j.taap.2018.03.020", "29571711"]}, {"Citation": "Laird M.D., Sukumari-Ramesh S., Swift A.E.B., Meiler S.E., Vender J.R., Dhandapani K.M. Curcumin attenuates cerebral edema following traumatic brain injury in mice: A possible role for aquaporin-4? J. Neurochem. 2010;113:637\u2013648. doi: 10.1111/j.1471-4159.2010.06630.x.", "ArticleIdList": ["10.1111/j.1471-4159.2010.06630.x", "PMC2911034", "20132469"]}, {"Citation": "Requejo-Aguilar R., Alastrue-Agudo A., Cases-Villar M., Lopez-Mocholi E., England R., Vicent M.J., Moreno-Manzano V. Combined polymer-curcumin conjugate and ependymal progenitor/stem cell treatment enhances spinal cord injury functional recovery. Biomaterials. 2017;113:18\u201330. doi: 10.1016/j.biomaterials.2016.10.032.", "ArticleIdList": ["10.1016/j.biomaterials.2016.10.032", "27810639"]}, {"Citation": "Aggarwal B.B. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu. Rev. Nutr. 2010;30:173\u2013199. doi: 10.1146/annurev.nutr.012809.104755.", "ArticleIdList": ["10.1146/annurev.nutr.012809.104755", "PMC3144156", "20420526"]}, {"Citation": "Acar A., Akil E., Alp H., Evliyaoglu O., Kibrisli E., Inal A., Unan F., Tasdemir N. Oxidative damage is ameliorated by curcumin treatment in brain and sciatic nerve of diabetic rats. Int. J. Neurosci. 2012;122:367\u2013372. doi: 10.3109/00207454.2012.657380.", "ArticleIdList": ["10.3109/00207454.2012.657380", "22248035"]}, {"Citation": "Babu A., Mohammed S., Harikumar K. Curcumin for Neurological and Psychiatric Disorders. Elsevier; London, UK: 2019. Antioxidant Properties of Curcumin: Impact on Neurological Disorders; pp. 155\u2013167."}, {"Citation": "Tang Y., Chen A. Curcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signaling. Lab. Investig. 2014;94:503. doi: 10.1038/labinvest.2014.42.", "ArticleIdList": ["10.1038/labinvest.2014.42", "PMC4006284", "24614199"]}, {"Citation": "Paul S., Mahanta S. Association of heat-shock proteins in various neurodegenerative disorders: Is it a master key to open the therapeutic door? Mol. Cell. Biochem. 2014;386:45\u201361. doi: 10.1007/s11010-013-1844-y.", "ArticleIdList": ["10.1007/s11010-013-1844-y", "24096700"]}, {"Citation": "Surh Y.-J., Chun K.-S., Cha H.-H., Han S.S., Keum Y.-S., Park K.-K., Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-\u03baB activation. Mutat. Res. Fundament. Mol. Mech. Mutagen. 2001;480:243\u2013268. doi: 10.1016/S0027-5107(01)00183-X.", "ArticleIdList": ["10.1016/S0027-5107(01)00183-X", "11506818"]}, {"Citation": "Armstrong R.A. Plaques and tangles and the pathogenesis of Alzheimer\u2019s disease. Folia Neuropathol. 2006;44", "ArticleIdList": ["16565925"]}, {"Citation": "Tang M., Taghibiglou C. The mechanisms of action of curcumin in Alzheimer\u2019s disease. J. Alzheimers Dis. 2017;58:1003\u20131016. doi: 10.3233/JAD-170188.", "ArticleIdList": ["10.3233/JAD-170188", "28527218"]}, {"Citation": "Schneider L.S., Mangialasche F., Andreasen N., Feldman H., Giacobini E., Jones R., Mantua V., Mecocci P., Pani L., Winblad B. Clinical trials and late-stage drug development for Alzheimer\u2019s disease: An appraisal from 1984 to 2014. J. Intern. Med. 2014;275:251\u2013283. doi: 10.1111/joim.12191.", "ArticleIdList": ["10.1111/joim.12191", "PMC3956752", "24605808"]}, {"Citation": "Nakia B., Tony B. Alzheimer\u2019s disease and the neuroprotective effects of dietary curcumin. J. Psychol. Clin. Psychiatry. 2016;6:00354."}, {"Citation": "Chandra V., Pandav R., Dodge H., Johnston J., Belle S., DeKosky S., Ganguli M. Incidence of Alzheimer\u2019s disease in a rural community in India: The Indo\u2013US study. Neurology. 2001;57:985\u2013989. doi: 10.1212/WNL.57.6.985.", "ArticleIdList": ["10.1212/WNL.57.6.985", "11571321"]}, {"Citation": "Vas C.J., Pinto C., Panikker D., Noronha S., Deshpande N., Kulkarni L., Sachdeva S. Prevalence of dementia in an urban Indian population. Int. Psychogeriatr. 2001;13:439\u2013450. doi: 10.1017/S1041610201007852.", "ArticleIdList": ["10.1017/S1041610201007852", "12003250"]}, {"Citation": "Yanagisawa D., Shirai N., Amatsubo T., Taguchi H., Hirao K., Urushitani M., Morikawa S., Inubushi T., Kato M., Kato F. Relationship between the tautomeric structures of curcumin derivatives and their A\u03b2-binding activities in the context of therapies for Alzheimer\u2019s disease. Biomaterials. 2010;31:4179\u20134185. doi: 10.1016/j.biomaterials.2010.01.142.", "ArticleIdList": ["10.1016/j.biomaterials.2010.01.142", "20181392"]}, {"Citation": "Zhang X., Tian Y., Li Z., Tian X., Sun H., Liu H., Moore A., Ran C. Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer\u2019s disease. J. Am. Chem. Soc. 2013;135:16397\u201316409. doi: 10.1021/ja405239v.", "ArticleIdList": ["10.1021/ja405239v", "PMC3927838", "24116384"]}, {"Citation": "Zheng K., Dai X., Wu X., Wei Z., Fang W., Zhu Y., Zhang J., Chen X. Curcumin ameliorates memory decline via inhibiting BACE1 expression and \u03b2-Amyloid pathology in 5\u00d7 FAD transgenic mice. Mol. Neurobiol. 2017;54:1967\u20131977. doi: 10.1007/s12035-016-9802-9.", "ArticleIdList": ["10.1007/s12035-016-9802-9", "26910813"]}, {"Citation": "Xiong Z., Hongmei Z., Lu S., Yu L. Curcumin mediates presenilin-1 activity to reduce \u03b2-amyloid production in a model of Alzheimer\u2019s disease. Pharmacol. Rep. 2011;63:1101\u20131108. doi: 10.1016/S1734-1140(11)70629-6.", "ArticleIdList": ["10.1016/S1734-1140(11)70629-6", "22180352"]}, {"Citation": "Reinke A.A., Gestwicki J.E. Structure\u2013activity Relationships of amyloid beta-aggregation inhibitors based on curcumin: Influence of linker length and flexibility. Chem. Biol. Drug Des. 2007;70:206\u2013215. doi: 10.1111/j.1747-0285.2007.00557.x.", "ArticleIdList": ["10.1111/j.1747-0285.2007.00557.x", "17718715"]}, {"Citation": "Thapa A., Vernon B.C., De la Pe\u00f1a K., Soliz G., Moreno H.A., L\u00f3pez G.P., Chi E.Y. Membrane-mediated neuroprotection by curcumin from amyloid-\u03b2-peptide-induced toxicity. Langmuir. 2013;29:11713\u201311723. doi: 10.1021/la4020459.", "ArticleIdList": ["10.1021/la4020459", "24004419"]}, {"Citation": "Cai H.-Y., Yang J.-T., Wang Z.-J., Zhang J., Yang W., Wu M.-N., Qi J.-S. Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer\u2019s disease. Biochem. Biophys. Res. Commun. 2018;495:1034\u20131040. doi: 10.1016/j.bbrc.2017.11.114.", "ArticleIdList": ["10.1016/j.bbrc.2017.11.114", "29175324"]}, {"Citation": "Guillozet-Bongaarts A.L., Garcia-Sierra F., Reynolds M.R., Horowitz P.M., Fu Y., Wang T., Cahill M.E., Bigio E.H., Berry R.W., Binder L.I. Tau truncation during neurofibrillary tangle evolution in Alzheimer\u2019s disease. Neurobiol. Aging. 2005;26:1015\u20131022. doi: 10.1016/j.neurobiolaging.2004.09.019.", "ArticleIdList": ["10.1016/j.neurobiolaging.2004.09.019", "15748781"]}, {"Citation": "Wegmann S., Bennett R.E., Delorme L., Robbins A.B., Hu M., McKenzie D., Kirk M.J., Schiantarelli J., Tunio N., Amaral A.C. Experimental evidence for the age dependence of tau protein spread in the brain. Sci. Adv. 2019;5:eaaw6404. doi: 10.1126/sciadv.aaw6404.", "ArticleIdList": ["10.1126/sciadv.aaw6404", "PMC6594764", "31249873"]}, {"Citation": "Patil S.P., Tran N., Geekiyanage H., Liu L., Chan C. Curcumin-induced upregulation of the anti-tau cochaperone BAG2 in primary rat cortical neurons. Neurosci. Lett. 2013;554:121\u2013125. doi: 10.1016/j.neulet.2013.09.008.", "ArticleIdList": ["10.1016/j.neulet.2013.09.008", "PMC3825752", "24035895"]}, {"Citation": "Huang H.-C., Tang D., Xu K., Jiang Z.-F. Curcumin attenuates amyloid-\u03b2-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3\u03b2 signaling pathway. J. Recept. Signal Transduct. 2014;34:26\u201337. doi: 10.3109/10799893.2013.848891.", "ArticleIdList": ["10.3109/10799893.2013.848891", "24188406"]}, {"Citation": "Liu B., Hong J.-S. Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 2003;304:1\u20137. doi: 10.1124/jpet.102.035048.", "ArticleIdList": ["10.1124/jpet.102.035048", "12490568"]}, {"Citation": "Walker D.G., Lue L.-F. Immune phenotypes of microglia in human neurodegenerative disease: Challenges to detecting microglial polarization in human brains. Alzheimers Res. Ther. 2015;7:56. doi: 10.1186/s13195-015-0139-9.", "ArticleIdList": ["10.1186/s13195-015-0139-9", "PMC4543480", "26286145"]}, {"Citation": "Haque M.E., Kim I.-S., Jakaria M., Akther M., Choi D.-K. Importance of GPCR-Mediated Microglial Activation in Alzheimer\u2019s Disease. Front. Cell. Neurosci. 2018;12 doi: 10.3389/fncel.2018.00258.", "ArticleIdList": ["10.3389/fncel.2018.00258", "PMC6110855", "30186116"]}, {"Citation": "Shi X., Zheng Z., Li J., Xiao Z., Qi W., Zhang A., Wu Q., Fang Y. Curcumin inhibits A\u03b2-induced microglial inflammatory responses in vitro: Involvement of ERK1/2 and p38 signaling pathways. Neurosci. Lett. 2015;594:105\u2013110. doi: 10.1016/j.neulet.2015.03.045.", "ArticleIdList": ["10.1016/j.neulet.2015.03.045", "25818332"]}, {"Citation": "Porro C., Cianciulli A., Trotta T., Lofrumento D.D., Panaro M.A. Curcumin Regulates Anti-Inflammatory Responses by JAK/STAT/SOCS Signaling Pathway in BV-2 Microglial Cells. Biology. 2019;8:51. doi: 10.3390/biology8030051.", "ArticleIdList": ["10.3390/biology8030051", "PMC6784227", "31252572"]}, {"Citation": "Liu Z.-J., Li Z.-H., Liu L., Tang W.-X., Wang Y., Dong M.-R., Xiao C. Curcumin attenuates beta-amyloid-induced neuroinflammation via activation of peroxisome proliferator-activated receptor-gamma function in a rat model of Alzheimer\u2019s disease. Front. Pharmacol. 2016;7:261. doi: 10.3389/fphar.2016.00261.", "ArticleIdList": ["10.3389/fphar.2016.00261", "PMC4990744", "27594837"]}, {"Citation": "Zhang L., Fiala M., Cashman J., Sayre J., Espinosa A., Mahanian M., Zaghi J., Badmaev V., Graves M.C., Bernard G., et al. Curcuminoids enhance amyloid-\u03b2 uptake by macrophages of Alzheimer\u2019s disease patients. J. Alzheimers Dis. 2006;10:1\u20137. doi: 10.3233/JAD-2006-10101.", "ArticleIdList": ["10.3233/JAD-2006-10101", "16988474"]}, {"Citation": "Tsatsakis A., Docea A.O., Calina D., Tsarouhas K., Zamfira L.-M., Mitrut R., Sharifi-Rad J., Kovatsi L., Siokas V., Dardiotis E. A mechanistic and pathophysiological approach for stroke associated with drugs of abuse. J. Clin. Med. 2019;8:1295. doi: 10.3390/jcm8091295.", "ArticleIdList": ["10.3390/jcm8091295", "PMC6780697", "31450861"]}, {"Citation": "Collins L.M., Toulouse A., Connor T.J., Nolan Y.M. Contributions of central and systemic inflammation to the pathophysiology of Parkinson\u2019s disease. Neuropharmacology. 2012;62:2154\u20132168. doi: 10.1016/j.neuropharm.2012.01.028.", "ArticleIdList": ["10.1016/j.neuropharm.2012.01.028", "22361232"]}, {"Citation": "Stephenson J., Nutma E., van der Valk P., Amor S. Inflammation in CNS neurodegenerative diseases. Immunology. 2018;154:204\u2013219. doi: 10.1111/imm.12922.", "ArticleIdList": ["10.1111/imm.12922", "PMC5980185", "29513402"]}, {"Citation": "Padureanu R., Albu C.V., Mititelu R.R., Bacanoiu M.V., Docea A.O., Calina D., Padureanu V., Olaru G., Sandu R.E., Malin R.D. Oxidative Stress and Inflammation Interdependence in Multiple Sclerosis. J. Clin. Med. 2019;8:1815. doi: 10.3390/jcm8111815.", "ArticleIdList": ["10.3390/jcm8111815", "PMC6912446", "31683787"]}, {"Citation": "Tarafdar A., Pula G. The role of NADPH oxidases and oxidative stress in neurodegenerative disorders. Int. J. Mol. Sci. 2018;19:3824. doi: 10.3390/ijms19123824.", "ArticleIdList": ["10.3390/ijms19123824", "PMC6321244", "30513656"]}, {"Citation": "Hsieh H.-L., Yang C.-M. Role of redox signaling in neuroinflammation and neurodegenerative diseases. BioMed Res. Int. 2013;2013 doi: 10.1155/2013/484613.", "ArticleIdList": ["10.1155/2013/484613", "PMC3884773", "24455696"]}, {"Citation": "Mosley R.L., Benner E.J., Kadiu I., Thomas M., Boska M.D., Hasan K., Laurie C., Gendelman H.E. Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson\u2019s disease. Clin. Neurosci. Res. 2006;6:261\u2013281. doi: 10.1016/j.cnr.2006.09.006.", "ArticleIdList": ["10.1016/j.cnr.2006.09.006", "PMC1831679", "18060039"]}, {"Citation": "Von Bernhardi R., Eugenin J. Alzheimer\u2019s disease: Redox dysregulation as a common denominator for diverse pathogenic mechanisms. Antioxid. Redox Signal. 2012;16:974\u20131031. doi: 10.1089/ars.2011.4082.", "ArticleIdList": ["10.1089/ars.2011.4082", "22122400"]}, {"Citation": "Ak T., G\u00fcl\u00e7in \u0130. Antioxidant and radical scavenging properties of curcumin. Chem. Biol. Interact. 2008;174:27\u201337. doi: 10.1016/j.cbi.2008.05.003.", "ArticleIdList": ["10.1016/j.cbi.2008.05.003", "18547552"]}, {"Citation": "Abrahams S., Haylett W.L., Johnson G., Carr J.A., Bardien S. Antioxidant Effects of Curcumin in Models of Neurodegeneration, Ageing, Oxidative and NITROSATIVE Stress: A Review. Neuroscience. 2019 doi: 10.1016/j.neuroscience.2019.02.020.", "ArticleIdList": ["10.1016/j.neuroscience.2019.02.020", "30825584"]}, {"Citation": "Gibellini L., Bianchini E., De Biasi S., Nasi M., Cossarizza A., Pinti M. Natural compounds modulating mitochondrial functions. Evid. Based Complementary Altern. Med. 2015;2015 doi: 10.1155/2015/527209.", "ArticleIdList": ["10.1155/2015/527209", "PMC4489008", "26167193"]}, {"Citation": "Trujillo J., Granados-Castro L.F., Zazueta C., And\u00e9rica-Romero A.C., Chirino Y.I., Pedraza-Chaverr\u00ed J. Mitochondria as a target in the therapeutic properties of curcumin. Arch. Pharm. 2014;347:873\u2013884. doi: 10.1002/ardp.201400266.", "ArticleIdList": ["10.1002/ardp.201400266", "25243820"]}, {"Citation": "Nawab A., Li G., Liu W., Lan R., Wu J., Zhao Y., Kang K., Kieser B., Sun C., Tang S. Effect of Dietary Curcumin on the Antioxidant Status of Laying Hens under High-Temperature Conditions. Braz. J. Poult. Sci. 2019;21 doi: 10.1590/1806-9061-2018-0868.", "ArticleIdList": ["10.1590/1806-9061-2018-0868", "31789237"]}, {"Citation": "Nussbaum L., Hogea L.M., C\u0103lina D., Andreescu N., Gr\u0103dinaru R., \u0218tef\u0103nescu R., Puiu M. Modern treatment approaches in psychoses. Pharmacogenetic, neuroimagistic and clinical implications. Farmacia. 2017;65:75\u201381."}, {"Citation": "Buga A.-M., Docea A.O., Albu C., Malin R.D., Branisteanu D.E., Ianosi G., Ianosi S.L., Iordache A., Calina D. Molecular and cellular stratagem of brain metastases associated with melanoma. Oncol. Lett. 2019;17:4170\u20134175. doi: 10.3892/ol.2019.9933.", "ArticleIdList": ["10.3892/ol.2019.9933", "PMC6444343", "30944612"]}, {"Citation": "Xu Y., Quinn C.C. Transition between synaptic branch formation and synaptogenesis is regulated by the lin-4 microRNA. Dev. Biol. 2016;420:60\u201366. doi: 10.1016/j.ydbio.2016.10.010.", "ArticleIdList": ["10.1016/j.ydbio.2016.10.010", "PMC5841448", "27746167"]}, {"Citation": "Sarnat H.B., Flores-Sarnat L. Precocious and delayed neocortical synaptogenesis in fetal holoprosencephaly. Clin. Neuropathol. 2013;32:255\u2013268. doi: 10.5414/NP300588.", "ArticleIdList": ["10.5414/NP300588", "23380462"]}, {"Citation": "Dubourg C., Carr\u00e9 W., Hamdi-Roz\u00e9 H., Mouden C., Roume J., Abdelmajid B., Amram D., Baumann C., Chassaing N., Coubes C. Mutational spectrum in holoprosencephaly shows that FGF is a new major signaling pathway. Hum. Mutat. 2016;37:1329\u20131339. doi: 10.1002/humu.23038.", "ArticleIdList": ["10.1002/humu.23038", "27363716"]}, {"Citation": "Dabrowski A., Terauchi A., Strong C., Umemori H. Distinct sets of FGF receptors sculpt excitatory and inhibitory synaptogenesis. Development. 2015;142:1818\u20131830. doi: 10.1242/dev.115568.", "ArticleIdList": ["10.1242/dev.115568", "PMC4440923", "25926357"]}, {"Citation": "Gupta S.C., Prasad S., Kim J.H., Patchva S., Webb L.J., Priyadarsini I.K., Aggarwal B.B. Multitargeting by curcumin as revealed by molecular interaction studies. Nat. Prod. Rep. 2011;28:1937\u20131955. doi: 10.1039/c1np00051a.", "ArticleIdList": ["10.1039/c1np00051a", "PMC3604998", "21979811"]}, {"Citation": "Dong S., Zeng Q., Mitchell E.S., Xiu J., Duan Y., Li C., Tiwari J.K., Hu Y., Cao X., Zhao Z. Curcumin enhances neurogenesis and cognition in aged rats: Implications for transcriptional interactions related to growth and synaptic plasticity. PLoS ONE. 2012;7:e31211. doi: 10.1371/journal.pone.0031211.", "ArticleIdList": ["10.1371/journal.pone.0031211", "PMC3281036", "22359574"]}, {"Citation": "Cole G.M., Teter B., Frautschy S.A. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. Springer; Boston, MA, USA: 2007. Neuroprotective effects of curcumin; pp. 197\u2013212.", "ArticleIdList": ["PMC2527619", "17569212"]}, {"Citation": "Zatta P., Drago D., Bolognin S., Sensi S.L. Alzheimer\u2019s disease, metal ions and metal homeostatic therapy. Trends Pharmacol. Sci. 2009;30:346\u2013355. doi: 10.1016/j.tips.2009.05.002.", "ArticleIdList": ["10.1016/j.tips.2009.05.002", "19540003"]}, {"Citation": "Wanninger S., Lorenz V., Subhan A., Edelmann F.T. Metal complexes of curcumin\u2013synthetic strategies, structures and medicinal applications. Chem. Soc. Rev. 2015;44:4986\u20135002. doi: 10.1039/C5CS00088B.", "ArticleIdList": ["10.1039/C5CS00088B", "25964104"]}, {"Citation": "Shehzad A., Islam S.U., Lee Y.S. Curcumin for Neurological and Psychiatric Disorders. Elsevier; London, UK: 2019. Curcumin and Inflammatory Brain Diseases; pp. 437\u2013458."}, {"Citation": "Berk Z. Chapter 11\u2014Extraction. In: Berk Z., editor. Food Process Engineering and Technology. 3rd ed. Elsevier; London, UK: 2018. pp. 289\u2013310."}, {"Citation": "Mandal V., Dewanjee S., Sahu R., Mandal S.C. Design and optimization of ultrasound assisted extraction of curcumin as an effective alternative for conventional solid liquid extraction of natural products. Nat. Prod. Commun. 2009;4:95\u2013100. doi: 10.1177/1934578X0900400121.", "ArticleIdList": ["10.1177/1934578X0900400121", "19370883"]}, {"Citation": "Moghtaderi H., Sepehri H., Attari F. Combination of arabinogalactan and curcumin induces apoptosis in breast cancer cells in vitro and inhibits tumor growth via overexpression of p53 level in vivo. Biomed. Pharmacother. 2017;88:582\u2013594. doi: 10.1016/j.biopha.2017.01.072.", "ArticleIdList": ["10.1016/j.biopha.2017.01.072", "28152473"]}, {"Citation": "Padhye S., Chavan D., Pandey S., Deshpande J., Swamy K.V., Sarkar F.H. Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry. Mini Rev. Med. Chem. 2010;10:372\u2013387. doi: 10.2174/138955710791330891.", "ArticleIdList": ["10.2174/138955710791330891", "PMC3084451", "20370702"]}, {"Citation": "Stagos D., Amoutzias G.D., Matakos A., Spyrou A., Tsatsakis A.M., Kouretas D. Chemoprevention of liver cancer by plant polyphenols. Food Chem. Toxicol. 2012;50:2155\u20132170. doi: 10.1016/j.fct.2012.04.002.", "ArticleIdList": ["10.1016/j.fct.2012.04.002", "22521445"]}, {"Citation": "Kakarala M., Brenner D.E., Korkaya H., Cheng C., Tazi K., Ginestier C., Liu S., Dontu G., Wicha M.S. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res. Treat. 2010;122:777\u2013785. doi: 10.1007/s10549-009-0612-x.", "ArticleIdList": ["10.1007/s10549-009-0612-x", "PMC3039120", "19898931"]}, {"Citation": "Cioboat\u0103 R., G\u0103man A., Tra\u015fc\u0103 D., Ungureanu A., Docea A.O., Tomescu P., Gherghina F., Arsene A.L., Badiu C., Tsatsakis A.M., et al. Pharmacological management of non-alcoholic fatty liver disease: Atorvastatin versus pentoxifylline. Exp. Ther. Med. 2017;13:2375\u20132381. doi: 10.3892/etm.2017.4256.", "ArticleIdList": ["10.3892/etm.2017.4256", "PMC5443168", "28565851"]}, {"Citation": "Wojciechowski V.V., Calina D., Tsarouhas K., Pivnik A.V., Sergievich A.A., Kodintsev V.V., Filatova E.A., Ozcagli E., Docea A.O., Arsene A.L., et al. A guide to acquired vitamin K coagulophathy diagnosis and treatment: The Russian perspective. DARU J. Pharm. Sci. 2017;25:10. doi: 10.1186/s40199-017-0175-z.", "ArticleIdList": ["10.1186/s40199-017-0175-z", "PMC5393004", "28416008"]}, {"Citation": "Oyemitan I.A., Elusiyan C.A., Onifade A.O., Akanmu M.A., Oyedeji A.O., McDonald A.G. Neuropharmacological profile and chemical analysis of fresh rhizome essential oil of Curcuma longa (turmeric) cultivated in Southwest Nigeria. Toxicol. Rep. 2017;4:391\u2013398. doi: 10.1016/j.toxrep.2017.07.001.", "ArticleIdList": ["10.1016/j.toxrep.2017.07.001", "PMC5615139", "28959664"]}, {"Citation": "Zhou H., Beevers C.S., Huang S. The targets of curcumin. Curr. Drug Targets. 2011;12:332\u2013347. doi: 10.2174/138945011794815356.", "ArticleIdList": ["10.2174/138945011794815356", "PMC3025067", "20955148"]}, {"Citation": "Wahlang B., Pawar Y.B., Bansal A.K. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur. J. Pharm. Biopharm. 2011;77:275\u2013282. doi: 10.1016/j.ejpb.2010.12.006.", "ArticleIdList": ["10.1016/j.ejpb.2010.12.006", "21147222"]}, {"Citation": "Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 2007;4:807\u2013818. doi: 10.1021/mp700113r.", "ArticleIdList": ["10.1021/mp700113r", "17999464"]}, {"Citation": "Kidd P.M. Bioavailability and activity of phytosome complexes from botanical polyphenols: The silymarin, curcumin, green tea, and grape seed extracts. Altern. Med. Rev. 2009;14:226\u2013246.", "ArticleIdList": ["19803548"]}, {"Citation": "Maiti K., Mukherjee K., Gantait A., Saha B.P., Mukherjee P.K. Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int. J. Pharm. 2007;330:155\u2013163. doi: 10.1016/j.ijpharm.2006.09.025.", "ArticleIdList": ["10.1016/j.ijpharm.2006.09.025", "17112692"]}, {"Citation": "Marczylo T.H., Verschoyle R.D., Cooke D.N., Morazzoni P., Steward W.P., Gescher A.J. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother. Pharmacol. 2007;60:171\u2013177. doi: 10.1007/s00280-006-0355-x.", "ArticleIdList": ["10.1007/s00280-006-0355-x", "17051370"]}, {"Citation": "Tsatsakis A., Stratidakis A.K., Goryachaya A.V., Tzatzarakis M.N., Stivaktakis P.D., Docea A.O., Berdiaki A., Nikitovic D., Velonia K., Shtilman M.I., et al. In vitro blood compatibility and in vitro cytotoxicity of amphiphilic poly-N-vinylpyrrolidone nanoparticles. Food Chem. Toxicol. 2019;127:42\u201352. doi: 10.1016/j.fct.2019.02.041.", "ArticleIdList": ["10.1016/j.fct.2019.02.041", "30836108"]}, {"Citation": "Bhawana, Basniwal R.K., Buttar H.S., Jain V.K., Jain N. Curcumin nanoparticles: Preparation, characterization, and antimicrobial study. J. Agric. Food Chem. 2011;59:2056\u20132061. doi: 10.1021/jf104402t.", "ArticleIdList": ["10.1021/jf104402t", "21322563"]}, {"Citation": "Bisht S., Feldmann G., Soni S., Ravi R., Karikar C., Maitra A., Maitra A. Polymeric nanoparticle-encapsulated curcumin (\u201cnanocurcumin\u201d): A novel strategy for human cancer therapy. J. Nanobiotechnology. 2007;5:3. doi: 10.1186/1477-3155-5-3.", "ArticleIdList": ["10.1186/1477-3155-5-3", "PMC1868037", "17439648"]}, {"Citation": "Tonnesen H.H., Masson M., Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: Solubility, chemical and photochemical stability. Int. J. Pharm. 2002;244:127\u2013135. doi: 10.1016/S0378-5173(02)00323-X.", "ArticleIdList": ["10.1016/S0378-5173(02)00323-X", "12204572"]}, {"Citation": "Paolino D., Vero A., Cosco D., Pecora T.M., Cianciolo S., Fresta M., Pignatello R. Improvement of Oral Bioavailability of Curcumin upon Microencapsulation with Methacrylic Copolymers. Front. Pharmacol. 2016;7:485. doi: 10.3389/fphar.2016.00485.", "ArticleIdList": ["10.3389/fphar.2016.00485", "PMC5174134", "28066239"]}, {"Citation": "Mourtas S., Lazar A.N., Markoutsa E., Duyckaerts C., Antimisiaris S.G. Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease. Eur. J. Med. Chem. 2014;80:175\u2013183. doi: 10.1016/j.ejmech.2014.04.050.", "ArticleIdList": ["10.1016/j.ejmech.2014.04.050", "24780594"]}, {"Citation": "Li L., Braiteh F.S., Kurzrock R. Liposome-encapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer. 2005;104:1322\u20131331. doi: 10.1002/cncr.21300.", "ArticleIdList": ["10.1002/cncr.21300", "16092118"]}, {"Citation": "Ross C., Taylor M., Fullwood N., Allsop D. Liposome delivery systems for the treatment of Alzheimer\u2019s disease. Int. J. Nanomed. 2018;13:8507\u20138522. doi: 10.2147/IJN.S183117.", "ArticleIdList": ["10.2147/IJN.S183117", "PMC6296687", "30587974"]}, {"Citation": "Zhao L., Du J., Duan Y., Zang Y., Zhang H., Yang C., Cao F., Zhai G. Curcumin loaded mixed micelles composed of Pluronic P123 and F68: Preparation, optimization and in vitro characterization. Colloids Surf. B Biointerfaces. 2012;97:101\u2013108. doi: 10.1016/j.colsurfb.2012.04.017.", "ArticleIdList": ["10.1016/j.colsurfb.2012.04.017", "22609589"]}, {"Citation": "Lin C.C., Lin H.Y., Chi M.H., Shen C.M., Chen H.W., Yang W.J., Lee M.H. Preparation of curcumin microemulsions with food-grade soybean oil/lecithin and their cytotoxicity on the HepG2 cell line. Food Chem. 2014;154:282\u2013290. doi: 10.1016/j.foodchem.2014.01.012.", "ArticleIdList": ["10.1016/j.foodchem.2014.01.012", "24518344"]}, {"Citation": "Teixeira C.C., Mendonca L.M., Bergamaschi M.M., Queiroz R.H., Souza G.E., Antunes L.M., Freitas L.A. Microparticles Containing Curcumin Solid Dispersion: Stability, Bioavailability and Anti-Inflammatory Activity. AAPS PharmSciTech. 2016;17:252\u2013261. doi: 10.1208/s12249-015-0337-6.", "ArticleIdList": ["10.1208/s12249-015-0337-6", "PMC4984877", "26040724"]}, {"Citation": "Parikh A., Kathawala K., Li J., Chen C., Shan Z., Cao X., Zhou X.F., Garg S. Curcumin-loaded self-nanomicellizing solid dispersion system: Part II: In vivo safety and efficacy assessment against behavior deficit in Alzheimer disease. Drug Deliv. Transl. Res. 2018;8:1406\u20131420. doi: 10.1007/s13346-018-0570-0.", "ArticleIdList": ["10.1007/s13346-018-0570-0", "30117120"]}, {"Citation": "Vaz G.R., Hadrich G., Bidone J., Rodrigues J.L., Falkembach M.C., Putaux J.L., Hort M.A., Monserrat J.M., Varela Junior A.S., Teixeira H.F., et al. Development of Nasal Lipid Nanocarriers Containing Curcumin for Brain Targeting. J. Alzheimers Dis. 2017;59:961\u2013974. doi: 10.3233/JAD-160355.", "ArticleIdList": ["10.3233/JAD-160355", "28731428"]}, {"Citation": "Del Prado-Audelo M.L., Maga\u00f1a J.J., Mej\u00eda-Contreras B.A., Borbolla-Jim\u00e9nez F.V., Giraldo-Gomez D.M., Pi\u00f1a-Barba M.C., Quintanar-Guerrero D., Leyva-G\u00f3mez G. In vitro cell uptake evaluation of curcumin-loaded PCL/F68 nanoparticles for potential application in neuronal diseases. J. Drug Deliv. Sci. Technol. 2019;52:905\u2013914. doi: 10.1016/j.jddst.2019.05.042.", "ArticleIdList": ["10.1016/j.jddst.2019.05.042"]}, {"Citation": "Wang Z.H., Wang Z.Y., Sun C.S., Wang C.Y., Jiang T.Y., Wang S.L. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain. Biomaterials. 2010;31:908\u2013915. doi: 10.1016/j.biomaterials.2009.09.104.", "ArticleIdList": ["10.1016/j.biomaterials.2009.09.104", "19853292"]}, {"Citation": "Pinzaru I., Coricovac D., Dehelean C., Moac\u0103 E.-A., Mioc M., Baderca F., Sizemore I., Brittle S., Marti D., Calina C.D., et al. Stable PEG-coated silver nanoparticles\u2014A comprehensive toxicological profile. Food Chem. Toxicol. 2018;111:546\u2013556. doi: 10.1016/j.fct.2017.11.051.", "ArticleIdList": ["10.1016/j.fct.2017.11.051", "29191727"]}, {"Citation": "Marin E., Briceno M.I., Torres A., Caballero-George C. New Curcumin-Loaded Chitosan Nanocapsules: In Vivo Evaluation. Planta Med. 2017;83:877\u2013883. doi: 10.1055/s-0043-104633.", "ArticleIdList": ["10.1055/s-0043-104633", "28264204"]}, {"Citation": "Kalani A., Chaturvedi P. Curcumin-primed and curcumin-loaded exosomes: Potential neural therapy. Neural Regen. Res. 2017;12:205. doi: 10.4103/1673-5374.200799.", "ArticleIdList": ["10.4103/1673-5374.200799", "PMC5361498", "28400796"]}, {"Citation": "Wang H., Sui H., Zheng Y., Jiang Y., Shi Y., Liang J., Zhao L. Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT/GSK-3\u03b2 pathway. Nanoscale. 2019;11:7481\u20137496. doi: 10.1039/C9NR01255A.", "ArticleIdList": ["10.1039/C9NR01255A", "30942233"]}, {"Citation": "Cheng K.K., Chan P.S., Fan S., Kwan S.M., Yeung K.L., Wang Y.X., Chow A.H., Wu E.X., Baum L. Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer\u2019s disease mice using magnetic resonance imaging (MRI) Biomaterials. 2015;44:155\u2013172. doi: 10.1016/j.biomaterials.2014.12.005.", "ArticleIdList": ["10.1016/j.biomaterials.2014.12.005", "25617135"]}, {"Citation": "Huo X., Zhang Y., Jin X., Li Y., Zhang L. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid beta aggregation in Alzheimer\u2019s disease. J. Photochem. Photobiol. B. 2019;190:98\u2013102. doi: 10.1016/j.jphotobiol.2018.11.008.", "ArticleIdList": ["10.1016/j.jphotobiol.2018.11.008", "30504054"]}, {"Citation": "Blanco E., Shen H., Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 2015;33:941\u2013951. doi: 10.1038/nbt.3330.", "ArticleIdList": ["10.1038/nbt.3330", "PMC4978509", "26348965"]}, {"Citation": "Henrich-Noack P., Nikitovic D., Neagu M., Docea A.O., Engin A.B., Gelperina S., Shtilman M., Mitsias P., Tzanakakis G., Gozes I., et al. The blood-brain barrier and beyond: Nano-based neuropharmacology and the role of extracellular matrix. Nanomedicine. 2019;17:359\u2013379. doi: 10.1016/j.nano.2019.01.016.", "ArticleIdList": ["10.1016/j.nano.2019.01.016", "30759369"]}, {"Citation": "Garcia-Alloza M., Borrelli L.A., Rozkalne A., Hyman B.T., Bacskai B.J. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J. Neurochem. 2007;102:1095\u20131104. doi: 10.1111/j.1471-4159.2007.04613.x.", "ArticleIdList": ["10.1111/j.1471-4159.2007.04613.x", "17472706"]}, {"Citation": "Tosi G., Pederzoli F., Belletti D., Vandelli M.A., Forni F., Duskey J.T., Ruozi B. Chapter 2\u2014Nanomedicine in Alzheimer\u2019s disease: Amyloid beta targeting strategy. In: Sharma H.S., Aruna S., editors. Nanoneuroprotection and Nanoneurotoxicology. Volume 245 Elsevier; London, UK: 2019.", "ArticleIdList": ["30961872"]}, {"Citation": "Bukhari S.N., Jantan I., Masand V.H., Mahajan D.T., Sher M., Naeem-ul-Hassan M., Amjad M.W. Synthesis of alpha, beta-unsaturated carbonyl based compounds as acetylcholinesterase and butyrylcholinesterase inhibitors: Characterization, molecular modeling, QSAR studies and effect against amyloid beta-induced cytotoxicity. Eur. J. Med. Chem. 2014;83:355\u2013365. doi: 10.1016/j.ejmech.2014.06.034.", "ArticleIdList": ["10.1016/j.ejmech.2014.06.034", "24980117"]}, {"Citation": "Si G., Zhou S., Xu G., Wang J., Wu B., Zhou S. A curcumin-based NIR fluorescence probe for detection of amyloid-beta (A\u03b2) plaques in Alzheimer\u2019s disease. Dyes Pigm. 2019;163:509\u2013515. doi: 10.1016/j.dyepig.2018.12.003.", "ArticleIdList": ["10.1016/j.dyepig.2018.12.003"]}, {"Citation": "Mishra S., Palanivelu K. The effect of curcumin (turmeric) on Alzheimer\u2019s disease: An overview. Ann. Indian Acad. Neurol. 2008;11:13\u201319. doi: 10.4103/0972-2327.40220.", "ArticleIdList": ["10.4103/0972-2327.40220", "PMC2781139", "19966973"]}, {"Citation": "Fan Y., Yi J., Zhang Y., Yokoyama W. Fabrication of curcumin-loaded bovine serum albumin (BSA)-dextran nanoparticles and the cellular antioxidant activity. Food Chem. 2018;239:1210\u20131218. doi: 10.1016/j.foodchem.2017.07.075.", "ArticleIdList": ["10.1016/j.foodchem.2017.07.075", "28873542"]}, {"Citation": "Nakagawa Y., Chiba K. Diversity and plasticity of microglial cells in psychiatric and neurological disorders. Pharmacol. Ther. 2015;154:21\u201335. doi: 10.1016/j.pharmthera.2015.06.010.", "ArticleIdList": ["10.1016/j.pharmthera.2015.06.010", "26129625"]}, {"Citation": "Fan C., Song Q., Wang P., Li Y., Yang M., Liu B., Yu S.Y. Curcumin Protects Against Chronic Stress-induced Dysregulation of Neuroplasticity and Depression-like Behaviors via Suppressing IL-1beta Pathway in Rats. Neuroscience. 2018;392:92\u2013106. doi: 10.1016/j.neuroscience.2018.09.028.", "ArticleIdList": ["10.1016/j.neuroscience.2018.09.028", "30268781"]}, {"Citation": "Hucklenbroich J., Klein R., Neumaier B., Graf R., Fink G.R., Schroeter M., Rueger M.A. Aromatic-turmerone induces neural stem cell proliferation in vitro and in vivo. Stem Cell Res. Ther. 2014;5:100. doi: 10.1186/scrt500.", "ArticleIdList": ["10.1186/scrt500", "PMC4180255", "25928248"]}, {"Citation": "Calsolaro V., Edison P. Neuroinflammation in Alzheimer\u2019s disease: Current evidence and future directions. Alzheimers Dement. 2016;12:719\u2013732. doi: 10.1016/j.jalz.2016.02.010.", "ArticleIdList": ["10.1016/j.jalz.2016.02.010", "27179961"]}, {"Citation": "Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P.P., Kayed R., Glabe C.G., Frautschy S.A., et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 2005;280:5892\u20135901. doi: 10.1074/jbc.M404751200.", "ArticleIdList": ["10.1074/jbc.M404751200", "15590663"]}, {"Citation": "Salehi B., Stojanovic-Radic Z., Matejic J., Sharifi-Rad M., Anil Kumar N.V., Martins N., Sharifi-Rad J. The therapeutic potential of curcumin: A review of clinical trials. Eur. J. Med. Chem. 2019;163:527\u2013545. doi: 10.1016/j.ejmech.2018.12.016.", "ArticleIdList": ["10.1016/j.ejmech.2018.12.016", "30553144"]}, {"Citation": "Karunaweera N., Raju R., Gyengesi E., Munch G. Plant polyphenols as inhibitors of NF-kappaB induced cytokine production-a potential anti-inflammatory treatment for Alzheimer\u2019s disease? Front. Mol. Neurosci. 2015;8:24. doi: 10.3389/fnmol.2015.00024.", "ArticleIdList": ["10.3389/fnmol.2015.00024", "PMC4468843", "26136655"]}, {"Citation": "Jones S.V., Kounatidis I. Nuclear Factor-Kappa B and Alzheimer Disease, Unifying Genetic and Environmental Risk Factors from Cell to Humans. Front. Immunol. 2017;8:1805. doi: 10.3389/fimmu.2017.01805.", "ArticleIdList": ["10.3389/fimmu.2017.01805", "PMC5732234", "29312321"]}, {"Citation": "Xu Y., Ku B., Cui L., Li X., Barish P.A., Foster T.C., Ogle W.O. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res. 2007;1162:9\u201318. doi: 10.1016/j.brainres.2007.05.071.", "ArticleIdList": ["10.1016/j.brainres.2007.05.071", "17617388"]}, {"Citation": "Rainey-Smith S.R., Brown B.M., Sohrabi H.R., Shah T., Goozee K.G., Gupta V.B., Martins R.N. Curcumin and cognition: A randomised, placebo-controlled, double-blind study of community-dwelling older adults. Br. J. Nutr. 2016;115:2106\u20132113. doi: 10.1017/S0007114516001203.", "ArticleIdList": ["10.1017/S0007114516001203", "27102361"]}, {"Citation": "Small G.W., Siddarth P., Li Z., Miller K.J., Ercoli L., Emerson N.D., Martinez J., Wong K.P., Liu J., Merrill D.A., et al. Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial. Am. J. Geriatr. Psychiatry. 2018;26:266\u2013277. doi: 10.1016/j.jagp.2017.10.010.", "ArticleIdList": ["10.1016/j.jagp.2017.10.010", "29246725"]}, {"Citation": "Zhang R., Miller R.G., Madison C., Jin X., Honrada R., Harris W., Katz J., Forshew D.A., McGrath M.S. Systemic immune system alterations in early stages of Alzheimer\u2019s disease. J. Neuroimmunol. 2013;256:38\u201342. doi: 10.1016/j.jneuroim.2013.01.002.", "ArticleIdList": ["10.1016/j.jneuroim.2013.01.002", "PMC3641776", "23380586"]}, {"Citation": "Solito E., Sastre M. Microglia function in Alzheimer\u2019s disease. Front. Pharmacol. 2012;3:14. doi: 10.3389/fphar.2012.00014.", "ArticleIdList": ["10.3389/fphar.2012.00014", "PMC3277080", "22363284"]}, {"Citation": "Teter B., Morihara T., Lim G.P., Chu T., Jones M.R., Zuo X., Paul R.M., Frautschy S.A., Cole G.M. Curcumin restores innate immune Alzheimer\u2019s disease risk gene expression to ameliorate Alzheimer pathogenesis. Neurobiol. Dis. 2019;127:432\u2013448. doi: 10.1016/j.nbd.2019.02.015.", "ArticleIdList": ["10.1016/j.nbd.2019.02.015", "PMC8092921", "30951849"]}, {"Citation": "Fiala M., Liu P.T., Espinosa-Jeffrey A., Rosenthal M.J., Bernard G., Ringman J.M., Sayre J., Zhang L., Zaghi J., Dejbakhsh S., et al. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer\u2019s disease patients are improved by bisdemethoxycurcumin. Proc. Natl. Acad. Sci. USA. 2007;104:12849\u201312854. doi: 10.1073/pnas.0701267104.", "ArticleIdList": ["10.1073/pnas.0701267104", "PMC1937555", "17652175"]}, {"Citation": "Reglodi D., Renaud J., Tamas A., Tizabi Y., Socias S.B., Del-Bel E., Raisman-Vozari R. Novel tactics for neuroprotection in Parkinson\u2019s disease: Role of antibiotics, polyphenols and neuropeptides. Prog. Neurobiol. 2017;155:120\u2013148. doi: 10.1016/j.pneurobio.2015.10.004.", "ArticleIdList": ["10.1016/j.pneurobio.2015.10.004", "26542398"]}, {"Citation": "Kundu P., Das M., Tripathy K., Sahoo S.K. Delivery of Dual Drug Loaded Lipid Based Nanoparticles across the Blood-Brain Barrier Impart Enhanced Neuroprotection in a Rotenone Induced Mouse Model of Parkinson\u2019s Disease. ACS Chem. Neurosci. 2016;7:1658\u20131670. doi: 10.1021/acschemneuro.6b00207.", "ArticleIdList": ["10.1021/acschemneuro.6b00207", "27642670"]}, {"Citation": "Dolati S., Babaloo Z., Jadidi-Niaragh F., Ayromlou H., Sadreddini S., Yousefi M. Multiple sclerosis: Therapeutic applications of advancing drug delivery systems. Biomed. Pharmacother. 2017;86:343\u2013353. doi: 10.1016/j.biopha.2016.12.010.", "ArticleIdList": ["10.1016/j.biopha.2016.12.010", "28011382"]}, {"Citation": "Natarajan C., Bright J.J. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J. Immunol. 2002;168:6506\u20136513. doi: 10.4049/jimmunol.168.12.6506.", "ArticleIdList": ["10.4049/jimmunol.168.12.6506", "12055272"]}, {"Citation": "Mohajeri M., Sadeghizadeh M., Najafi F., Javan M. Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair. Neuropharmacology. 2015;99:156\u2013167. doi: 10.1016/j.neuropharm.2015.07.013.", "ArticleIdList": ["10.1016/j.neuropharm.2015.07.013", "26211978"]}, {"Citation": "Wang Y.J., Pan M.H., Cheng A.L., Lin L.I., Ho Y.S., Hsieh C.Y., Lin J.K. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 1997;15:1867\u20131876. doi: 10.1016/S0731-7085(96)02024-9.", "ArticleIdList": ["10.1016/S0731-7085(96)02024-9", "9278892"]}, {"Citation": "Sharma R.A., Steward W.P., Gescher A.J. Pharmacokinetics and pharmacodynamics of curcumin. In: Aggarwal B.B., Surh Y.-J., Shishodia S., editors. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. Springer; Boston, MA, USA: 2007. pp. 453\u2013470.", "ArticleIdList": ["10.1007/978-0-387-46401-5_20", "17569224"]}, {"Citation": "Sadegh Malvajerd S., Azadi A., Izadi Z., Kurd M., Dara T., Dibaei M., Sharif Zadeh M., Akbari Javar H., Hamidi M. Brain Delivery of Curcumin Using Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Preparation, Optimization, and Pharmacokinetic Evaluation. ACS Chem. Neurosci. 2019;10:728\u2013739. doi: 10.1021/acschemneuro.8b00510.", "ArticleIdList": ["10.1021/acschemneuro.8b00510", "30335941"]}, {"Citation": "Lombardo D., Kiselev M.A., Caccamo M.T. Smart Nanoparticles for Drug Delivery Application: Development of Versatile Nanocarrier Platforms in Biotechnology and Nanomedicine. J. Nanomater. 2019;2019:26. doi: 10.1155/2019/3702518.", "ArticleIdList": ["10.1155/2019/3702518"]}, {"Citation": "Tosi G., Costantino L., Ruozi B., Forni F., Vandelli M.A. Polymeric nanoparticles for the drug delivery to the central nervous system. Expert Opin. Drug Deliv. 2008;5:155\u2013174. doi: 10.1517/17425247.5.2.155.", "ArticleIdList": ["10.1517/17425247.5.2.155", "18248316"]}, {"Citation": "Cai Q., Wang L., Deng G., Liu J., Chen Q., Chen Z. Systemic delivery to central nervous system by engineered PLGA nanoparticles. Am. J. Transl. Res. 2016;8:749\u2013764.", "ArticleIdList": ["PMC4846924", "27158367"]}, {"Citation": "Tsai Y.M., Jan W.C., Chien C.F., Lee W.C., Lin L.C., Tsai T.H. Optimised nano-formulation on the bioavailability of hydrophobic polyphenol, curcumin, in freely-moving rats. Food Chem. 2011;127:918\u2013925. doi: 10.1016/j.foodchem.2011.01.059.", "ArticleIdList": ["10.1016/j.foodchem.2011.01.059", "25214079"]}, {"Citation": "Tsai Y.M., Chien C.F., Lin L.C., Tsai T.H. Curcumin and its nano-formulation: The kinetics of tissue distribution and blood-brain barrier penetration. Int. J. Pharm. 2011;416:331\u2013338. doi: 10.1016/j.ijpharm.2011.06.030.", "ArticleIdList": ["10.1016/j.ijpharm.2011.06.030", "21729743"]}, {"Citation": "Doggui S., Sahni J.K., Arseneault M., Dao L., Ramassamy C. Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line. J. Alzheimers Dis. 2012;30:377\u2013392. doi: 10.3233/JAD-2012-112141.", "ArticleIdList": ["10.3233/JAD-2012-112141", "22426019"]}, {"Citation": "Djiokeng Paka G., Doggui S., Zaghmi A., Safar R., Dao L., Reisch A., Klymchenko A., Roullin V.G., Joubert O., Ramassamy C. Neuronal Uptake and Neuroprotective Properties of Curcumin-Loaded Nanoparticles on SK-N-SH Cell Line: Role of Poly(lactide-co-glycolide) Polymeric Matrix Composition. Mol. Pharm. 2016;13:391\u2013403. doi: 10.1021/acs.molpharmaceut.5b00611.", "ArticleIdList": ["10.1021/acs.molpharmaceut.5b00611", "26618861"]}, {"Citation": "Mulik R.S., Monkkonen J., Juvonen R.O., Mahadik K.R., Paradkar A.R. ApoE3 mediated polymeric nanoparticles containing curcumin: Apoptosis induced in vitro anticancer activity against neuroblastoma cells. Int. J. Pharm. 2012;437:29\u201341. doi: 10.1016/j.ijpharm.2012.07.062.", "ArticleIdList": ["10.1016/j.ijpharm.2012.07.062", "22890189"]}, {"Citation": "Mulik R.S., Monkkonen J., Juvonen R.O., Mahadik K.R., Paradkar A.R. ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: Study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model. Mol. Pharm. 2010;7:815\u2013825. doi: 10.1021/mp900306x.", "ArticleIdList": ["10.1021/mp900306x", "20230014"]}, {"Citation": "Karewicz A., Bielska D., Loboda A., Gzyl-Malcher B., Bednar J., Jozkowicz A., Dulak J., Nowakowska M. Curcumin-containing liposomes stabilized by thin layers of chitosan derivatives. Colloids Surf. B Biointerfaces. 2013;109:307\u2013316. doi: 10.1016/j.colsurfb.2013.03.059.", "ArticleIdList": ["10.1016/j.colsurfb.2013.03.059", "23668985"]}, {"Citation": "Yadav A., Lomash V., Samim M., Flora S.J. Curcumin encapsulated in chitosan nanoparticles: A novel strategy for the treatment of arsenic toxicity. Chem. Biol. Interact. 2012;199:49\u201361. doi: 10.1016/j.cbi.2012.05.011.", "ArticleIdList": ["10.1016/j.cbi.2012.05.011", "22704994"]}, {"Citation": "Yang R., Zheng Y., Wang Q., Zhao L. Curcumin-loaded chitosan-bovine serum albumin nanoparticles potentially enhanced Abeta 42 phagocytosis and modulated macrophage polarization in Alzheimer\u2019s disease. Nanoscale Res. Lett. 2018;13:330. doi: 10.1186/s11671-018-2759-z.", "ArticleIdList": ["10.1186/s11671-018-2759-z", "PMC6197340", "30350003"]}, {"Citation": "Chiappetta D.A., Sosnik A. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs. Eur. J. Pharm. Biopharm. 2007;66:303\u2013317. doi: 10.1016/j.ejpb.2007.03.022.", "ArticleIdList": ["10.1016/j.ejpb.2007.03.022", "17481869"]}, {"Citation": "Lombardo D., Munao G., Calandra P., Pasqua L., Caccamo M.T. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS-PEO block copolymer. Phys. Chem. Chem. Phys. 2019;21:11983\u201311991. doi: 10.1039/C9CP02195G.", "ArticleIdList": ["10.1039/C9CP02195G", "31134980"]}, {"Citation": "Nance E.A., Woodworth G.F., Sailor K.A., Shih T.Y., Xu Q., Swaminathan G., Xiang D., Eberhart C., Hanes J. A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Sci. Transl. Med. 2012;4:149ra119. doi: 10.1126/scitranslmed.3003594.", "ArticleIdList": ["10.1126/scitranslmed.3003594", "PMC3718558", "22932224"]}, {"Citation": "Suk J.S., Xu Q., Kim N., Hanes J., Ensign L.M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev. 2016;99:28\u201351. doi: 10.1016/j.addr.2015.09.012.", "ArticleIdList": ["10.1016/j.addr.2015.09.012", "PMC4798869", "26456916"]}, {"Citation": "Joseph A., Wood T., Chen C.-C., Corry K., Snyder J.M., Juul S.E., Parikh P., Nance E. Curcumin-loaded polymeric nanoparticles for neuroprotection in neonatal rats with hypoxic-ischemic encephalopathy. Nano Res. 2018;11:5670\u20135688. doi: 10.1007/s12274-018-2104-y.", "ArticleIdList": ["10.1007/s12274-018-2104-y"]}, {"Citation": "Song Z., Feng R., Sun M., Guo C., Gao Y., Li L., Zhai G. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo. J. Colloid Interface Sci. 2011;354:116\u2013123. doi: 10.1016/j.jcis.2010.10.024.", "ArticleIdList": ["10.1016/j.jcis.2010.10.024", "21044788"]}, {"Citation": "Mathew A., Fukuda T., Nagaoka Y., Hasumura T., Morimoto H., Yoshida Y., Maekawa T., Venugopal K., Kumar D.S. Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer\u2019s disease. PLoS ONE. 2012;7:e32616. doi: 10.1371/journal.pone.0032616.", "ArticleIdList": ["10.1371/journal.pone.0032616", "PMC3293842", "22403681"]}, {"Citation": "Paka G.D., Ramassamy C. Optimization of Curcumin-Loaded PEG-PLGA Nanoparticles by GSH Functionalization: Investigation of the Internalization Pathway in Neuronal Cells. Mol. Pharm. 2017;14:93\u2013106. doi: 10.1021/acs.molpharmaceut.6b00738.", "ArticleIdList": ["10.1021/acs.molpharmaceut.6b00738", "27744707"]}, {"Citation": "Huang N., Lu S., Liu X.G., Zhu J., Wang Y.J., Liu R.T. PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Abeta generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer\u2019s disease mice. Oncotarget. 2017;8:81001\u201381013. doi: 10.18632/oncotarget.20944.", "ArticleIdList": ["10.18632/oncotarget.20944", "PMC5655257", "29113362"]}, {"Citation": "Ebrahim Attia A.B., Ong Z.Y., Hedrick J.L., Lee P.P., Ee P.L.R., Hammond P.T., Yang Y.-Y. Mixed micelles self-assembled from block copolymers for drug delivery. Curr. Opin. Colloid Interface Sci. 2011;16:182\u2013194. doi: 10.1016/j.cocis.2010.10.003.", "ArticleIdList": ["10.1016/j.cocis.2010.10.003"]}, {"Citation": "Ji S., Lin X., Yu E., Dian C., Yan X., Li L., Zhang M., Zhao W., Dian L. Curcumin-Loaded Mixed Micelles: Preparation, Characterization, and In Vitro Antitumor Activity. J. Nanotechnol. 2018;2018:9. doi: 10.1155/2018/9103120.", "ArticleIdList": ["10.1155/2018/9103120"]}, {"Citation": "Puri A., Loomis K., Smith B., Lee J.H., Yavlovich A., Heldman E., Blumenthal R. Lipid-based nanoparticles as pharmaceutical drug carriers: From concepts to clinic. Crit. Rev. Ther. Drug Carrier Syst. 2009;26:523\u2013580. doi: 10.1615/CritRevTherDrugCarrierSyst.v26.i6.10.", "ArticleIdList": ["10.1615/CritRevTherDrugCarrierSyst.v26.i6.10", "PMC2885142", "20402623"]}, {"Citation": "Katsaras J., Gutberlet T. Lipid Bilayers. Structure and Interactions. Springer; Berlin/Heidelberg, Germany: 2001.", "ArticleIdList": ["10.1007/978-3-662-04496-4"]}, {"Citation": "Kiselev M.A., Lombardo D. Structural characterization in mixed lipid membrane systems by neutron and X-ray scattering. Biochim. Biophys. Acta Gen. Subj. 2017;1861:3700\u20133717. doi: 10.1016/j.bbagen.2016.04.022.", "ArticleIdList": ["10.1016/j.bbagen.2016.04.022", "27138452"]}, {"Citation": "Lombardo D., Calandra P., Barreca D., Magazu S., Kiselev M.A. Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery. Nanomaterials. 2016;6:125. doi: 10.3390/nano6070125.", "ArticleIdList": ["10.3390/nano6070125", "PMC5224599", "28335253"]}, {"Citation": "Mishra V., Bansal K.K., Verma A., Yadav N., Thakur S., Sudhakar K., Rosenholm J.M. Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems. Pharmaceutics. 2018;10:191. doi: 10.3390/pharmaceutics10040191.", "ArticleIdList": ["10.3390/pharmaceutics10040191", "PMC6321253", "30340327"]}, {"Citation": "Khosa A., Reddi S., Saha R.N. Nanostructured lipid carriers for site-specific drug delivery. Biomed. Pharmacother. 2018;103:598\u2013613. doi: 10.1016/j.biopha.2018.04.055.", "ArticleIdList": ["10.1016/j.biopha.2018.04.055", "29677547"]}, {"Citation": "Naseri N., Valizadeh H., Zakeri-Milani P. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application. Adv. Pharm. Bull. 2015;5:305\u2013313. doi: 10.15171/apb.2015.043.", "ArticleIdList": ["10.15171/apb.2015.043", "PMC4616893", "26504751"]}, {"Citation": "Gastaldi L., Battaglia L., Peira E., Chirio D., Muntoni E., Solazzi I., Gallarate M., Dosio F. Solid lipid nanoparticles as vehicles of drugs to the brain: Current state of the art. Eur. J. Pharm. Biopharm. 2014;87:433\u2013444. doi: 10.1016/j.ejpb.2014.05.004.", "ArticleIdList": ["10.1016/j.ejpb.2014.05.004", "24833004"]}, {"Citation": "Ganesan P., Kim B., Ramalaingam P., Karthivashan G., Revuri V., Park S., Kim J.S., Ko Y.T., Choi D.K. Antineuroinflammatory Activities and Neurotoxicological Assessment of Curcumin Loaded Solid Lipid Nanoparticles on LPS-Stimulated BV-2 Microglia Cell Models. Molecules. 2019;24:1170. doi: 10.3390/molecules24061170.", "ArticleIdList": ["10.3390/molecules24061170", "PMC6470586", "30934561"]}, {"Citation": "Maiti P., Dunbar G.L. Comparative Neuroprotective Effects of Dietary Curcumin and Solid Lipid Curcumin Particles in Cultured Mouse Neuroblastoma Cells after Exposure to Abeta42. Int. J. Alzheimers Dis. 2017;2017 doi: 10.1155/2017/4164872.", "ArticleIdList": ["10.1155/2017/4164872", "PMC5439264", "28567323"]}, {"Citation": "Sadegh Malvajerd S., Izadi Z., Azadi A., Kurd M., Derakhshankhah H., Sharifzadeh M., Akbari Javar H., Hamidi M. Neuroprotective Potential of Curcumin-Loaded Nanostructured Lipid Carrier in an Animal Model of Alzheimer\u2019s Disease: Behavioral and Biochemical Evidence. J. Alzheimers Dis. 2019;69:671\u2013686. doi: 10.3233/JAD-190083.", "ArticleIdList": ["10.3233/JAD-190083", "31156160"]}, {"Citation": "Chen Y., Pan L., Jiang M., Li D., Jin L. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo. Drug Deliv. 2016;23:1383\u20131392. doi: 10.3109/10717544.2015.1049719.", "ArticleIdList": ["10.3109/10717544.2015.1049719", "26066035"]}, {"Citation": "Kaur I.P., Bhandari R., Bhandari S., Kakkar V. Potential of solid lipid nanoparticles in brain targeting. J. Control. Release. 2008;127:97\u2013109. doi: 10.1016/j.jconrel.2007.12.018.", "ArticleIdList": ["10.1016/j.jconrel.2007.12.018", "18313785"]}, {"Citation": "Bozzuto G., Molinari A. Liposomes as nanomedical devices. Int. J. Nanomed. 2015;10:975\u2013999. doi: 10.2147/IJN.S68861.", "ArticleIdList": ["10.2147/IJN.S68861", "PMC4324542", "25678787"]}, {"Citation": "Vieira D.B., Gamarra L.F. Getting into the brain: Liposome-based strategies for effective drug delivery across the blood-brain barrier. Int. J. Nanomed. 2016;11:5381\u20135414. doi: 10.2147/IJN.S117210.", "ArticleIdList": ["10.2147/IJN.S117210", "PMC5077137", "27799765"]}, {"Citation": "Daraee H., Etemadi A., Kouhi M., Alimirzalu S., Akbarzadeh A. Application of liposomes in medicine and drug delivery. Artif. Cells Nanomed. Biotechnol. 2016;44:381\u2013391. doi: 10.3109/21691401.2014.953633.", "ArticleIdList": ["10.3109/21691401.2014.953633", "25222036"]}, {"Citation": "Lombardo D., Calandra P., Bellocco E., Lagana G., Barreca D., Magazu S., Wanderlingh U., Kiselev M.A. Effect of anionic and cationic polyamidoamine (PAMAM) dendrimers on a model lipid membrane. Biochim. Biophys. Acta. 2016;1858:2769\u20132777. doi: 10.1016/j.bbamem.2016.08.001.", "ArticleIdList": ["10.1016/j.bbamem.2016.08.001", "27521487"]}, {"Citation": "Lombardo D., Calandra P., Magazu S., Wanderlingh U., Barreca D., Pasqua L., Kiselev M.A. Soft nanoparticles charge expression within lipid membranes: The case of amino terminated dendrimers in bilayers vesicles. Colloids Surf. B Biointerfaces. 2018;170:609\u2013616. doi: 10.1016/j.colsurfb.2018.06.031.", "ArticleIdList": ["10.1016/j.colsurfb.2018.06.031", "29975909"]}, {"Citation": "Balducci C., Mancini S., Minniti S., La Vitola P., Zotti M., Sancini G., Mauri M., Cagnotto A., Colombo L., Fiordaliso F., et al. Multifunctional liposomes reduce brain beta-amyloid burden and ameliorate memory impairment in Alzheimer\u2019s disease mouse models. J. Neurosci. 2014;34:14022\u201314031. doi: 10.1523/JNEUROSCI.0284-14.2014.", "ArticleIdList": ["10.1523/JNEUROSCI.0284-14.2014", "PMC4198543", "25319699"]}, {"Citation": "Lazar A.N., Mourtas S., Youssef I., Parizot C., Dauphin A., Delatour B., Antimisiaris S.G., Duyckaerts C. Curcumin-conjugated nanoliposomes with high affinity for Abeta deposits: Possible applications to Alzheimer disease. Nanomedicine. 2013;9:712\u2013721. doi: 10.1016/j.nano.2012.11.004.", "ArticleIdList": ["10.1016/j.nano.2012.11.004", "23220328"]}, {"Citation": "Gao J.Q., Lv Q., Li L.M., Tang X.J., Li F.Z., Hu Y.L., Han M. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes. Biomaterials. 2013;34:5628\u20135639. doi: 10.1016/j.biomaterials.2013.03.097.", "ArticleIdList": ["10.1016/j.biomaterials.2013.03.097", "23628475"]}, {"Citation": "Chen Z.L., Huang M., Wang X.R., Fu J., Han M., Shen Y.Q., Xia Z., Gao J.Q. Transferrin-modified liposome promotes alpha-mangostin to penetrate the blood-brain barrier. Nanomedicine. 2016;12:421\u2013430. doi: 10.1016/j.nano.2015.10.021.", "ArticleIdList": ["10.1016/j.nano.2015.10.021", "26711963"]}, {"Citation": "Chen H., Tang L., Qin Y., Yin Y., Tang J., Tang W., Sun X., Zhang Z., Liu J., He Q. Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery. Eur. J. Pharm. Sci. 2010;40:94\u2013102. doi: 10.1016/j.ejps.2010.03.007.", "ArticleIdList": ["10.1016/j.ejps.2010.03.007", "20298779"]}, {"Citation": "Lindgren M., Hallbrink M., Prochiantz A., Langel U. Cell-penetrating peptides. Trends Pharmacol. Sci. 2000;21:99\u2013103. doi: 10.1016/S0165-6147(00)01447-4.", "ArticleIdList": ["10.1016/S0165-6147(00)01447-4", "10689363"]}, {"Citation": "Vives E., Richard J.P., Rispal C., Lebleu B. TAT peptide internalization: Seeking the mechanism of entry. Curr. Protein Pept. Sci. 2003;4:125\u2013132. doi: 10.2174/1389203033487306.", "ArticleIdList": ["10.2174/1389203033487306", "12678851"]}, {"Citation": "Sancini G., Gregori M., Salvati E., Cambianica L., Re F., Ornaghi F., Canovi M., Fracasso C., Cagnotto A., Colombo M., et al. Functionalization with TAT-Peptide Enhances Blood-Brain Barrier Crossing In vitro of Nanoliposomes Carrying a Curcumin-Derivative to Bind Amyloid-\u0392 Peptide. J. Nanomed. Nanotechnol. 2013;4:1\u20138. doi: 10.4172/2157-7439.1000171.", "ArticleIdList": ["10.4172/2157-7439.1000171"]}, {"Citation": "Taylor M., Moore S., Mourtas S., Niarakis A., Re F., Zona C., La Ferla B., Nicotra F., Masserini M., Antimisiaris S.G., et al. Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer\u2019s Abeta peptide. Nanomedicine. 2011;7:541\u2013550. doi: 10.1016/j.nano.2011.06.015.", "ArticleIdList": ["10.1016/j.nano.2011.06.015", "21722618"]}, {"Citation": "Madheswaran T., Kandasamy M., Bose R.J., Karuppagounder V. Current potential and challenges in the advances of liquid crystalline nanoparticles as drug delivery systems. Drug Discov. Today. 2019;24:1405\u20131412. doi: 10.1016/j.drudis.2019.05.004.", "ArticleIdList": ["10.1016/j.drudis.2019.05.004", "31102731"]}, {"Citation": "Wei L., Li X., Guo F., Liu X., Wang Z. Structural properties, in vitro release and radical scavenging activity of lecithin based curcumin-encapsulated inverse hexagonal (HII) liquid crystals. Colloids Surf. 2018;539:124\u2013131. doi: 10.1016/j.colsurfa.2017.11.071.", "ArticleIdList": ["10.1016/j.colsurfa.2017.11.071"]}, {"Citation": "Angelova A., Drechsler M., Garamus V.M., Angelov B. Liquid Crystalline Nanostructures as PEGylated Reservoirs of Omega-3 Polyunsaturated Fatty Acids: Structural Insights toward Delivery Formulations against Neurodegenerative Disorders. ACS Omega. 2018;3:3235\u20133247. doi: 10.1021/acsomega.7b01935.", "ArticleIdList": ["10.1021/acsomega.7b01935", "PMC6044969", "30023865"]}, {"Citation": "Baskaran R., Madheswaran T., Sundaramoorthy P., Kim H.M., Yoo B.K. Entrapment of curcumin into monoolein-based liquid crystalline nanoparticle dispersion for enhancement of stability and anticancer activity. Int. J. Nanomed. 2014;9:3119\u20133130. doi: 10.2147/ijn.s61823.", "ArticleIdList": ["10.2147/ijn.s61823", "PMC4079637", "25061290"]}, {"Citation": "Coisne C., Tilloy S., Monflier E., Wils D., Fenart L., Gosselet F. Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases. Molecules. 2016;21:1748. doi: 10.3390/molecules21121748.", "ArticleIdList": ["10.3390/molecules21121748", "PMC6273856", "27999408"]}, {"Citation": "Ramdani L., Bourboulou R., Belkouch M., Jebors S., Tauran Y., Parizot C., Suwinska K., Coleman A.W., Duyckaerts C., Lazar A.N. Multifunctional Curcumin-Nanocarriers Based on Host-Guest Interactions for Alzheimer Disease Diagnostic. J. Nanomed. Nanotechnol. 2015;6 doi: 10.4172/2157-7439.1000270.", "ArticleIdList": ["10.4172/2157-7439.1000270"]}, {"Citation": "Quitschke W.W., Steinhauff N., Rooney J. The effect of cyclodextrin-solubilized curcuminoids on amyloid plaques in Alzheimer transgenic mice: Brain uptake and metabolism after intravenous and subcutaneous injection. Alzheimers Res. Ther. 2013;5:16. doi: 10.1186/alzrt170.", "ArticleIdList": ["10.1186/alzrt170", "PMC3706801", "23537472"]}, {"Citation": "Cheng K.K., Yeung C.F., Ho S.W., Chow S.F., Chow A.H., Baum L. Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer\u2019s disease Tg2576 mice. AAPS J. 2013;15:324\u2013336. doi: 10.1208/s12248-012-9444-4.", "ArticleIdList": ["10.1208/s12248-012-9444-4", "PMC3675736", "23229335"]}, {"Citation": "Mendes M., Sousa J.J., Pais A., Vitorino C. Targeted Theranostic Nanoparticles for Brain Tumor Treatment. Pharmaceutics. 2018;10:181. doi: 10.3390/pharmaceutics10040181.", "ArticleIdList": ["10.3390/pharmaceutics10040181", "PMC6321593", "30304861"]}, {"Citation": "Ramanathan S., Archunan G., Sivakumar M., Tamil Selvan S., Fred A.L., Kumar S., Gulyas B., Padmanabhan P. Theranostic applications of nanoparticles in neurodegenerative disorders. Int. J. Nanomed. 2018;13:5561\u20135576. doi: 10.2147/IJN.S149022.", "ArticleIdList": ["10.2147/IJN.S149022", "PMC6154717", "30271147"]}, {"Citation": "Ghorbani M., Bigdeli B., Jalili-Baleh L., Baharifar H., Akrami M., Dehghani S., Goliaei B., Amani A., Lotfabadi A., Rashedi H., et al. Curcumin-lipoic acid conjugate as a promising anticancer agent on the surface of goldiron oxide nanocomposites: A pH-sensitive targeted drug delivery system for brain cancer theranostics. Eur. J. Pharm. Sci. 2018;114:175\u2013188. doi: 10.1016/j.ejps.2017.12.008.", "ArticleIdList": ["10.1016/j.ejps.2017.12.008", "29248558"]}, {"Citation": "Gamage N.H., Jing L., Worsham M.J., Ali M.M. Targeted Theranostic Approach for Glioma Using Dendrimer-Based Curcumin Nanoparticle. J. Nanomed. Nanotechnol. 2016;7 doi: 10.4172/2157-7439.1000393.", "ArticleIdList": ["10.4172/2157-7439.1000393", "PMC5040461", "27699139"]}, {"Citation": "Jaruszewski K.M., Curran G.L., Swaminathan S.K., Rosenberg J.T., Grant S.C., Ramakrishnan S., Lowe V.J., Poduslo J.F., Kandimalla K.K. Multimodal nanoprobes to target cerebrovascular amyloid in Alzheimer\u2019s disease brain. Biomaterials. 2014;35:1967\u20131976. doi: 10.1016/j.biomaterials.2013.10.075.", "ArticleIdList": ["10.1016/j.biomaterials.2013.10.075", "PMC3970424", "24331706"]}, {"Citation": "Pasqua L., Leggio A., Sisci D., Ando S., Morelli C. Mesoporous Silica Nanoparticles in Cancer Therapy: Relevance of the Targeting Function. Mini Rev. Med. Chem. 2016;16:743\u2013753. doi: 10.2174/1389557516666160321113620.", "ArticleIdList": ["10.2174/1389557516666160321113620", "26996622"]}, {"Citation": "Bagheri E., Ansari L., Abnous K., Taghdisi S.M., Charbgoo F., Ramezani M., Alibolandi M. Silica based hybrid materials for drug delivery and bioimaging. J. Control. Release. 2018;277:57\u201376. doi: 10.1016/j.jconrel.2018.03.014.", "ArticleIdList": ["10.1016/j.jconrel.2018.03.014", "29550399"]}, {"Citation": "Vallet-Regi M., Colilla M., Izquierdo-Barba I., Manzano M. Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights. Molecules. 2017;23:47. doi: 10.3390/molecules23010047.", "ArticleIdList": ["10.3390/molecules23010047", "PMC5943960", "29295564"]}, {"Citation": "Pasqua L., De Napoli I.E., De Santo M., Greco M., Catizzone E., Lombardo D., Montera G., Comand\u00e8 A., Nigro A., Morelli C., et al. Mesoporous silica-based hybrid materials for bone-specific drug delivery. Nanoscale Adv. 2019;1:3269\u20133278. doi: 10.1039/C9NA00249A.", "ArticleIdList": ["10.1039/C9NA00249A", "PMC9417532", "36133588"]}, {"Citation": "Jambhrunkar S., Karmakar S., Popat A., Yu M., Yu C. Mesoporous silica nanoparticles enhance the cytotoxicity of curcumin. RSC Adv. 2014;4:709\u2013712. doi: 10.1039/C3RA44257H.", "ArticleIdList": ["10.1039/C3RA44257H"]}, {"Citation": "Ceresa C., Nicolini G., Rigolio R., Bossi M., Pasqua L., Cavaletti G. Functionalized mesoporous silica nanoparticles: A possible strategy to target cancer cells reducing peripheral nervous system uptake. Curr. Med. Chem. 2013;20:2589\u20132600. doi: 10.2174/0929867311320200007.", "ArticleIdList": ["10.2174/0929867311320200007", "23627934"]}, {"Citation": "Nigro A., Pellegrino M., Greco M., Comande A., Sisci D., Pasqua L., Leggio A., Morelli C. Dealing with Skin and Blood-Brain Barriers: The Unconventional Challenges of Mesoporous Silica Nanoparticles. Pharmaceutics. 2018;10:250. doi: 10.3390/pharmaceutics10040250.", "ArticleIdList": ["10.3390/pharmaceutics10040250", "PMC6320758", "30513731"]}, {"Citation": "Lungare S., Hallam K., Badhan R.K. Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery. Int. J. Pharm. 2016;513:280\u2013293. doi: 10.1016/j.ijpharm.2016.09.042.", "ArticleIdList": ["10.1016/j.ijpharm.2016.09.042", "27633279"]}, {"Citation": "Ahmadi Nasab N., Hassani Kumleh H., Beygzadeh M., Teimourian S., Kazemzad M. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment. Artif. Cells Nanomed. Biotechnol. 2018;46:75\u201381. doi: 10.1080/21691401.2017.1290648.", "ArticleIdList": ["10.1080/21691401.2017.1290648", "28278578"]}]}], "History": [{"Year": "2020", "Month": "1", "Day": "4"}, {"Year": "2020", "Month": "1", "Day": "31"}, {"Year": "2020", "Month": "2", "Day": "3"}, {"Year": "2020", "Month": "2", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "9", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "2", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["32033365", "PMC7074182", "10.3390/jcm9020430", "jcm9020430"]}}]}